Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-16

Clinical Trial Update: Efficacy of Suvorexant in Patients With Effectively Treated Restless Legs Syndrome and Persistent Chronic Insomnia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating suvorexant for efficacy in patients with effectively treated restless legs syndrome and persistent chronic insomnia; results posted aft…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Suvorexant (suvorexant)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Restless Legs Syndrome, Insomnia | Phase 4 | Status: COMPLETED | Results posted: 2024-01-16